BAL-2420

N/A

Report date: 2026/03/31 20:00:21
NMEFirst In Class

Base Information

Drug NameBAL-2420
Drug Alias NameBAL-2420BAL2420
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionLipopolysaccharide export system protein LptA inhibitors
TargetsLipopolysaccharide export system protein LptA
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsSwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSpexis AGBasilea Pharmaceutica Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBasilea Pharmaceutica LtdBasilea PharmaceuticaCARB-X
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A